Facebook
Twitter
LinkedIn
Forward2019 ASCO Review
To provide a comprehensive overview of topics of greatest importance as presented at the 2019 ASCO Annual Meeting.
Target Audience
Oncologists and other health care professionals providing care to individuals with cancer.
Learning Objectives
Upon completion of this conference the participant should be able to:
- Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to cancer patients.
- Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers.
- Stimulate innovative strategies for new and/or additional research related to treatment and/or prevention.
- Recognize the implications for practice change in both the academic and community practice settings.
Additional Information
| Attachment | Size |
|---|---|
 Save the Date post card APPROVED.pdf | 460.84 KB |
| ASCO Handout - 2019 (002) APPROVED.pdf | 176.87 KB |
7:30 am | Registration & Breakfast |
|
8:00 am | Introduction & Welcome | Edward Chu, MD |
8:10 am | GU Cancer | Lenonard J. Appleman, M.D., PhD Roby A. ThomaS |
9:10 am | Non-Colorectal GI Cancer | Nathan Bahary, M.D., PhD John Rhee, M.D. |
10:10 am | Break |
|
10:30 am | Breast Cancer | Priya Rastogi, M.D. Shannon Puhalla, M.D. |
11:30 am | Colorectal Cancer | Edward Chu, M.D. Rajesh Sehgal, MBBS M.D. FACP |
12:30 pm | Lunch |
|
1:30 pm | Melanoma | Yana Najjar, M.D. Diwakar Davar, M.D. |
2:30 pm | Lung CaNcer | Liza C. Villaruz, M.D. Dan Petro, M.D. |
3:30pm | Adjournment |
|
Leonard J. Appleman MD PhD Director, Genitourinary Cancer Disease Section Associate Professor of Medicine University of Pittsburgh Department of Medicine, Division of Hematology/Oncology
Nathan Bahary MD, PhD Associate Professor of Medicine Medical Director - Pancreatic Cancer Program Co-Director - UPMC Pancreatic Cancer Center of Excellence. Pathways Chair-Pancreatic Cancers and Neuroendocrine Tumors University of Pittsburgh School of Medicine Department of Medicine-Division of Oncology Department of Molecular Genetics and Developmental Biology
Diwakar Davar, MD Faculty - Clinician, Physician Hematology Oncology UPMC Hillman Cancer Center
Edward Chu, MD Professor of Medicine, Pharmacology & Chemical Biology, and Clinical & Translational Science Stanley M. Marks, MD-OHA Chair in Hematology-Oncology Research Chief, Division of Hematology-Oncology Deputy Director, UPMC Hillman Cancer Center University of Pittsburgh School of Medicine
Yana Najjar, MD Faculty - Clinician, Physician Hematology Oncology UPMC Hillman Cancer Center
| Priya Rastogi, MD Faculty - Research, Physician UPMC Hillman Cancer Center
Roby A. Thomas Hematologist Oncologist Department of Hematology/Oncology University of Pittsburgh Medical Center Hillman Cancer CenteR
Shannon Puhalla, MD UPMC Hillman Cancer Center UPMC Passavant UPMC MageE
John C. Rhee, M.D. Clinical Assistant Professor of Medicine UPMC Hillman Cancer Center
Dan Petro, MD Assistant Clinical Professor of Medicine Regional Medical Director UPMC Hillman Cancer Center
Vice President of Medical Affairs Chief – Division of Hematology and Medical Oncology UPMC East Monroeville, PA
Liza C. Villaruz, MD Assistant Professor of Medicine UPMC Hillman Cancer Center |
All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
The following relevant financial relationships were disclosed:
- Dr Nathan Bahary- Grant/ Research Support- Pfizer; Consultant- BioLine Rx, AstraZeneca, Exelixis, Bristol Meyer Squibb, Thermo Fisher
- Dr Diwakar Daval – Grant/Research Support and Consultant – Tesaro, Merck, BMS, Checkmate Pharmaceuticals, Amgen
- Shannon Puhalla- Consultant- Abbvie, Esai
- Priya Rastogi – Travel and Accommodations- Lilly, Genentech/Roche, AstraZeneca
- Yana Najjar, MD- Grant/ Research Support- Merck; Advisory Board- Array
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 6.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 6.00 Attendance
To receive credit, login and complete the course evaluation and/or claim credit on the CCEHS Learning Portal , http://cce.upmc.com. The activity is accessible in your Pending Activities. If you are a new user, click Register to create a new account.
Certificates will be available to download and stored for future reference in your Completed Activities.
To answer common questions or for step by step instructions please visit the FAQs available on the CCEHS Learning Portal.